HealthEquity Inc

NASDAQ HQY

Data sourced from iex and EODHD
Download Data

HealthEquity Inc Income Statement 2013 - 2024

This table shows the Income Statement for HealthEquity Inc going from 2013 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-01-31 2023-10-31 2023-07-31 2023-04-30 2023-01-31 2022-10-31 2022-07-31 2022-04-30 2022-01-31 2021-10-31 2021-07-31 2021-04-30 2021-01-31 2020-10-31 2020-07-31 2020-04-30 2020-01-31 2019-10-31 2019-07-31 2019-04-30 2019-01-31 2018-10-31 2018-07-31 2018-04-30 2018-01-31 2017-10-31 2017-07-31 2017-04-30 2017-01-31 2016-10-31 2016-07-31 2016-04-30 2016-01-31 2015-10-31 2015-07-31 2015-04-30 2015-01-31 2014-10-31 2014-07-31 2014-04-30 2014-01-31 2013-10-31 2013-07-31 2013-04-30 2013-01-31
Revenue
M 1,000 971 938 901 862 831 795 778 757 741 741 728 734 747 724 635 532 407 320 304 287 272 258 244 230 216 202 190 178 167 155 141 127 116 107 97 88 80 74 68 62 57 42 27 12
Cost of Revenue
M 402 380 378 374 372 370 357 346 333 322 320 317 318 319 305 259 206 150 113 110 106 104 102 98 95 88 83 77 72 67 62 59 54 49 46 43 40 36 34 31 29 27 20 13 6
Gross Profit
M 597 591 560 527 490 461 438 432 424 419 421 410 415 428 420 376 326 257 206 195 181 168 156 146 135 127 120 112 106 101 92 82 73 67 61 54 48 44 40 37 33 50 42 34 26
Operating Expenses
M 477 493 480 466 451 469 458 459 448 416 406 385 380 378 371 312 249 178 118 110 104 99 92 87 80 75 72 69 65 61 56 51 46 43 39 35 31 27 24 23 21 39 34 30 25
Selling, General, and Administrative Expenses (SG&A)
M 104 99 98 97 96 96 91 87 84 86 89 86 84 85 82 71 61 46 36 34 33 31 28 27 25 23 22 21 20 19 17 16 14 14 13 10 8 7 5 4 4 8 7 6 5
Research and Development (R&D) Expenses
M 219 216 210 201 193 187 176 167 157 144 136 129 125 124 117 98 78 56 41 38 35 33 31 29 27 26 26 24 22 21 19 18 17 15 14 12 11 9 8 8 7 9 8 6 4
Other Operating Expenses
M 155 178 173 168 162 187 192 204 206 186 181 170 170 169 172 143 111 76 42 38 35 35 33 31 28 26 24 23 23 22 20 18 16 14 13 13 12 12 11 11 10 22 20 18 16
Costs and Expenses
M 67 106 98 91 81 73 61 56 50 43 39 28 17 16 14 8 11 7 2 0 -3 -5 -10 -12 -14 -13 -11 -9 -7 -6 -7 -8 -8 -6 -6 -8 -9 -9 -9 -9 -8 -12 -11 -9 -6
Operating Income
M 120 98 80 60 39 -8 -21 -27 -24 3 15 25 36 50 49 64 77 79 88 85 78 70 64 59 54 52 48 44 41 39 37 31 26 24 22 19 17 16 16 14 12 11 7 4 1
Interest Expense
M 55 56 55 53 48 45 45 40 37 33 28 29 35 43 46 37 25 10 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Non-operating Income/Expense
M -25 -33 -53 -70 -77 -90 -81 -79 -71 -47 -45 -40 -41 -46 -86 -78 -41 -29 18 22 -2 -3 -2 -2 -2 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 0 -1 -7 -7 -7 -6 0 0 0 0
EBT
M 75 45 18 -10 -38 -82 -85 -79 -67 -24 -11 -4 4 5 -31 -6 43 60 109 107 76 66 62 57 52 51 47 43 40 38 36 30 26 23 21 19 16 10 9 7 5 16 13 9 7
Income Tax Provision
M 19 16 5 -2 -12 -23 -23 -23 -22 -18 -12 -8 -5 2 -11 -6 3 7 19 13 2 0 0 1 5 6 6 11 14 13 13 11 9 8 7 7 6 5 6 5 4 4 2 1 0
Income after Tax
M 56 29 13 -8 -26 -59 -62 -55 -44 -6 1 4 9 3 -20 0 40 53 90 93 74 67 61 56 47 46 41 32 26 25 24 20 17 15 14 12 10 4 3 2 1 12 10 8 7
Non-Controlling Interest
M 0 0 0 0 0 0 0 -50 -50 -50 -50 0 0 -28 -28 -19 0 28 28 19 0 0 0 0 0 0 0 0 0 0 0 0 0 9 9 10 8 0 -2 -6 -5 -17 -15 -13 -11
Net Income
M 15 14 13 -8 -26 -59 -62 -5 6 44 51 4 9 3 -20 0 40 53 90 93 74 67 61 56 47 46 41 32 26 25 24 20 17 15 14 11 9 7 6 6 5 17 15 13 11
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 86,750,000.00 86,070,750.00 85,433,250.00 84,958,750.00 84,438,750.00 84,186,250.00 83,931,000.00 83,690,500.00 83,121,750.00 81,834,500.00 80,408,000.00 77,623,500.00 75,259,750.00 73,340,000.00 71,509,750.00 69,819,750.00 67,722,000.00 65,933,000.00 64,282,750.00 63,736,250.00 63,434,250.00 63,076,000.00 62,562,250.00 62,154,250.00 61,831,000.00 61,419,500.00 60,970,750.00 60,442,250.00 59,942,000.00 59,635,750.00 59,433,250.00 59,253,500.00 58,846,250.00 58,375,000.00 57,947,500.00 53,634,500.00 51,591,026.25 39,241,026.25 35,272,776.25 35,272,776.25 33,293,750.00 41,680,000.00 41,680,000.00 41,680,000.00 -
EBITDA
M 275 256 248 226 200 172 155 160 160 176 189 186 199 202 169 158 136 105 113 103 96 88 82 76 70 67 62 58 54 50 44 36 28 25 23 21 19 19 19 18 16 13 8 4 -
Depreciation and Amortization
M 144 146 164 166 161 160 139 131 123 115 125 120 116 112 102 78 55 33 19 18 18 18 18 17 16 15 14 14 13 11 8 5 2 2 2 2 2 3 4 5 4 3 2 1 -
EBIT
M 131 109 85 60 39 13 16 29 36 61 65 66 83 90 68 80 80 71 94 85 78 70 64 59 54 52 48 44 41 39 37 31 26 24 22 19 17 16 15 14 11 10 6 3 0
Income from Discontinued Operations
M - - - - - - - - - - - - - - - - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Tax Rate (Effective)
% 31.61 706.91 717.67 717.06 708.40 36.53 29.36 36.30 44.41 163.14 166.11 173.02 161.46 53.65 47.42 32.38 34.32 22.10 16.67 10.87 3.78 1.88 4.48 4.93 10.27 15.35 18.16 27.69 33.83 32.49 33.68 34.00 34.21 34.58 32.11 32.96 34.17 24.58 27.78 27.27 26.46 28.89 25.42 19.22 0.00
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -
Gross Profit Margin
% 59.85 60.86 59.64 58.44 56.83 55.43 55.10 55.62 56.10 56.56 56.78 56.43 56.66 57.37 58.08 60.49 62.86 63.40 64.36 63.88 63.16 61.59 60.19 59.54 58.89 58.74 58.82 59.24 59.75 59.65 59.18 58.26 57.54 57.27 56.80 55.65 54.81 54.50 54.25 54.09 53.02 93.05 105.75 130.78 209.19
Operating Income Margin
% 11.93 10.09 8.43 6.54 4.37 -1.06 -2.55 -3.31 -2.94 0.43 2.08 3.48 4.89 6.68 6.65 12.54 18.51 22.17 27.33 27.74 27.13 25.15 24.39 24.05 23.89 23.71 22.95 22.91 23.25 22.98 22.93 21.87 21.03 20.02 19.77 19.69 19.79 20.08 20.73 20.69 18.91 18.34 17.03 13.48 6.95
Net Income Margin
% 3.01 1.98 1.29 -1.09 -3.16 -7.18 -7.69 -0.23 1.07 5.82 6.77 0.59 1.18 0.44 -3.20 2.41 14.18 18.53 27.49 29.82 25.89 24.00 23.05 22.58 20.83 20.56 19.41 16.62 14.88 14.89 14.77 13.73 13.32 12.51 12.62 10.87 10.06 7.60 7.39 9.22 8.86 32.54 39.06 51.18 90.39
EBITDA Ratio
% 27.48 26.35 26.41 25.02 23.13 20.68 19.50 20.60 21.19 23.71 25.54 25.55 27.14 27.13 22.85 26.36 28.50 29.05 34.91 33.83 33.47 31.93 31.31 31.03 30.82 30.59 30.04 30.19 30.64 29.11 27.42 24.90 22.72 21.35 21.23 21.26 22.45 23.72 25.97 27.12 25.46 29.13 28.43 26.21 -
EBIT Ratio
% 13.07 11.22 8.93 6.54 4.37 1.48 2.26 3.93 5.00 8.26 8.72 9.04 11.33 12.05 8.83 14.98 19.36 21.67 28.94 27.74 27.13 25.15 24.39 24.05 23.89 23.71 22.95 22.91 23.25 22.98 22.93 21.87 21.03 19.92 19.67 19.55 19.53 19.57 20.40 20.36 18.57 16.60 14.47 9.75 0.00
EBT Ratio
% 7.43 4.60 1.77 -1.37 -4.59 -9.97 -10.53 -9.87 -8.50 -3.30 -1.46 -0.52 0.57 0.67 -4.88 2.07 16.53 22.00 33.16 33.86 26.48 23.87 23.48 23.16 22.96 23.39 22.66 22.61 22.63 22.41 22.60 21.11 20.55 19.49 18.98 19.30 18.46 10.26 10.86 10.80 9.90 29.32 31.97 36.03 52.62

StockViz Staff

September 16, 2024

Any question? Send us an email